1
|
Konaté A, Barro-Kiki PCM, Kassi KF, Angora KE, Vanga-Bosson H, Djohan V, Bédia-Tanoh AV, Miézan AJS, Yavo W, Menan EIH. Oropharyngeal candidiasis prevalence among HIV-infected patients at the teaching hospital of Treichville (Abidjan, Côte d'Ivoire). J Mycol Med 2017; 27:549-553. [PMID: 28867257 DOI: 10.1016/j.mycmed.2017.08.005] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2017] [Revised: 08/08/2017] [Accepted: 08/10/2017] [Indexed: 11/15/2022]
Abstract
AIM OF THE STUDY The aim of this study was to determine the mycological profile of oropharyngeal candidiasis among HIV-infected patients from Internal Medicine, Infectious and Tropical Diseases, and Pneumo-Phthisiology Diseases departments of the Teaching Hospital of Treichville in Abidjan, Côte d'Ivoire. PATIENTS AND METHODS This was a cross-sectional study carried out on patients with lesions suggestive of oropharyngeal candidiasis from October 2010 to April 2011. Oral swabs were cultured, and Candida species were identified using a germ tube test, a chlamydospore formation assay, and the API 20C system. RESULTS A total of 286 patients were included, among whom 99.1% were infected with HIV. The prevalence of oropharyngeal candidiasis was 79.4% (CI95%=74.4-83.8). Five different species of Candida were identified, with the predominant species being Candida albicans (95.2%). Most affected patients were female (54.6%, P<0.0001) between the ages of 30 and 45 (78.4%, P<0.0001). The most lesion types observed were thrush (87.8%). Patients infected with HIV1 (95.6%), with a primary school level of education (52.8%), under antiretroviral therapy (88.5%) and with tuberculosis as an associated pathology (62.5%) were the most commonly affected. Patients were mostly under ART first line treatment (86.4%) and at the beginning of the treatment (86.4%). CONCLUSION Oropharyngeal candidiasis is frequent among HIV-infected patients. Better and early management of this vulnerable population should allow for a reduction in the high prevalence observed.
Collapse
Affiliation(s)
- A Konaté
- Department of parasitology, Mycology, Animal Biology and Zoology, Felix-Houphouët-Boigny University, BPV 34, Abidjan, Cote d'Ivoire; Laboratory of Parasitology and Mycology, Teaching Hospital of Yopougon, 21 BP 632, Abidjan 21, Cote d'Ivoire.
| | - P C M Barro-Kiki
- Department of parasitology, Mycology, Animal Biology and Zoology, Felix-Houphouët-Boigny University, BPV 34, Abidjan, Cote d'Ivoire
| | - K F Kassi
- Department of parasitology, Mycology, Animal Biology and Zoology, Felix-Houphouët-Boigny University, BPV 34, Abidjan, Cote d'Ivoire; Laboratory of Parasitology And Mycology of the Diagnosis and Research Centre on AIDS and the others infectious diseases, 01 BPV 13, Abidjan, Cote d'Ivoire
| | - K E Angora
- Department of parasitology, Mycology, Animal Biology and Zoology, Felix-Houphouët-Boigny University, BPV 34, Abidjan, Cote d'Ivoire
| | - H Vanga-Bosson
- Department of parasitology, Mycology, Animal Biology and Zoology, Felix-Houphouët-Boigny University, BPV 34, Abidjan, Cote d'Ivoire
| | - V Djohan
- Department of parasitology, Mycology, Animal Biology and Zoology, Felix-Houphouët-Boigny University, BPV 34, Abidjan, Cote d'Ivoire
| | - A V Bédia-Tanoh
- Department of parasitology, Mycology, Animal Biology and Zoology, Felix-Houphouët-Boigny University, BPV 34, Abidjan, Cote d'Ivoire
| | - A J S Miézan
- Department of parasitology, Mycology, Animal Biology and Zoology, Felix-Houphouët-Boigny University, BPV 34, Abidjan, Cote d'Ivoire
| | - W Yavo
- Department of parasitology, Mycology, Animal Biology and Zoology, Felix-Houphouët-Boigny University, BPV 34, Abidjan, Cote d'Ivoire
| | - E I H Menan
- Department of parasitology, Mycology, Animal Biology and Zoology, Felix-Houphouët-Boigny University, BPV 34, Abidjan, Cote d'Ivoire; Laboratory of Parasitology And Mycology of the Diagnosis and Research Centre on AIDS and the others infectious diseases, 01 BPV 13, Abidjan, Cote d'Ivoire
| |
Collapse
|
3
|
Zannou DM, Kindé-Gazard D, Vigan J, Adè G, Sèhonou JJ, Atadokpèdé F, Azondékon A, Gbèdo C, Anagonou SY, Houngbé F. [Clinical and immunological profile of HIV infected patients in Cotonou, Benin]. Med Mal Infect 2006; 34:225-8. [PMID: 16235600 DOI: 10.1016/j.medmal.2004.02.007] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
OBJECTIVES This study had for aim to identify the clinical status and the level of immuno-deficiency of HIV-infected patients on their first visit. METHODS One hundred and thirty-six HIV+ patients were prospectively evaluated from November 1, 2001 to May 31, 2002. RESULTS One hundred and thirty-four were infected with HIV1 and two with HIV2. The mean age on the first consultation was 37 +/- 2 years. The m/w sex ratio was 0.9. 46.3% were stage C. The main clinical symptoms were: weight loss (88%), fever (80%), cough (71%), diarrhea (51%). BMI was normal in 70% and KI > or =80% in 57% of the cases but immuno-deficiency was severe with CD4 cells count <200 per mm3 in 69%. The main diseases were digestive candidiasis (53%), pneumonia (18%), tuberculosis (12%), non-determined pneumonia (29%), prurigo (20%), zona (16%), cryptosporidiosis (4%), cerebral toxoplasmosis (3%), and Kaposi's sarcoma (1%).
Collapse
Affiliation(s)
- D M Zannou
- Service de médecine interne, CNHU H.K.-Maga, 01 BP 386 Cotonou, Bénin.
| | | | | | | | | | | | | | | | | | | |
Collapse
|